{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T23:10:17Z","timestamp":1772320217133,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"General project \u201cMolecular mechanism of circTCEA1 promoting hepatocellular carcinoma by regulating p53 protein modification\u201d","award":["82173010"],"award-info":[{"award-number":["82173010"]}]},{"name":"Regional Science Foundation project \u201cEffect and molecular mechanism of lncRNA DACT3-AS1 on hepatocellular carcinoma metastasis under hypoxia\u201d","award":["81960531"],"award-info":[{"award-number":["81960531"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatocellular carcinoma (HCC), as the most common type of liver cancer, is characterized by high recurrence and metastasis. Circular RNA (circRNA) circ_0036412 was selected for studying the underlying mechanisms of HCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Quantitative real time-polymerase chain reaction (qRT-PCR) and western blot analyzed gene and protein expression. Functional experiments evaluated HCC cell proliferation, apoptosis and cell cycle in vitro. In vivo experiments detected HCC carcinogenesis in vivo. Fluorescence in situ hybridization (FISH) assays evaluated the subcellular distribution. Luciferase reporter, Chromatin immunoprecipitation (ChIP), DNA pulldown, RNA-binding protein immunoprecipitation (RIP), and RNA pulldown assays detected the underlying mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Circ_0036412 is overexpressed in HCC cells and features circular structure. PRDM1 activates circ_0036412 transcription to regulate the proliferation and cell cycle of HCC cells in vitro. Circ_0036412 modulates Hedgehog pathway. GLI2 propels HCC growth in vivo. Circ_0036412 up-regulates GLI2 expression by competitively binding to miR-579-3p, thus promoting the proliferation and inhibiting cell cycle arrest of HCC cells. Circ_0036412 stabilizes GLI2 expression by recruiting ELAVL1. Circ_0036412 propels the proliferation and inhibits cell cycle arrest of HCC cells in vitro through Hedgehog pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Circ_0036412 affects the proliferation and cell cycle of HCC via Hedgehog signaling pathway. It offers an insight into the targeted therapies of HCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12967-022-03305-x","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:09:36Z","timestamp":1649156976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Circ_0036412 affects the proliferation and cell cycle of hepatocellular carcinoma via hedgehog signaling pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Liyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyuan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuhua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"3305_CR1","doi-asserted-by":"publisher","first-page":"e9944","DOI":"10.7717\/peerj.9944","volume":"8","author":"W Zhou","year":"2020","unstructured":"Zhou W, Zhang S, Cai Z, Gao F, Deng W, Wen Y, Qiu ZW, Hou ZK, Chen XL. A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma. PeerJ. 2020;8:e9944.","journal-title":"PeerJ"},{"key":"3305_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41419-020-03276-1","volume":"11","author":"G Huang","year":"2020","unstructured":"Huang G, Liang M, Liu H, Huang J, Li P, Wang C, Zhang Y, Lin Y, Jiang X. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p\/RTKN2 axis and activating Wnt\/\u03b2-catenin pathway. Cell Death Dis. 2020;11:1065.","journal-title":"Cell Death Dis"},{"key":"3305_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3305_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00247-015-3497-3","volume":"46","author":"L Wu","year":"2016","unstructured":"Wu L, Zhao L, Lu Y, He L, Hu X. Interventional embolization of congenital intrahepatic shunts in children. Pediatr Radiol. 2016;46:541\u20137.","journal-title":"Pediatr Radiol"},{"key":"3305_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jceh.2019.01.004","volume":"9","author":"A Jindal","year":"2019","unstructured":"Jindal A, Thadi A, Shailubhai K. Hepatocellular carcinoma: etiology and current and future drugs. J Clin Exp Hepatol. 2019;9:221\u201332.","journal-title":"J Clin Exp Hepatol"},{"key":"3305_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2147\/JHC.S325629","volume":"8","author":"YQ Che","year":"2021","unstructured":"Che YQ, Zhang Y, Li HB, Shen D, Cui W. Serum KLKB1 as a potential prognostic biomarker for hepatocellular carcinoma based on data-independent acquisition and parallel reaction monitoring. J Hepatocell Carcinoma. 2021;8:1241\u201352.","journal-title":"J Hepatocell Carcinoma"},{"key":"3305_CR7","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3390\/ijms20061465","volume":"20","author":"I Lurje","year":"2019","unstructured":"Lurje I, Czigany Z, Bednarsch J, Roderburg C, Isfort P, Neumann UP, Lurje G. Treatment strategies for hepatocellular carcinoma\u2014a multidisciplinary approach. Int J Mol Sci. 2019;20:1465.","journal-title":"Int J Mol Sci"},{"key":"3305_CR8","doi-asserted-by":"publisher","first-page":"568366","DOI":"10.3389\/fcell.2020.568366","volume":"8","author":"T Seimiya","year":"2020","unstructured":"Seimiya T, Otsuka M, Iwata T, Shibata C, Tanaka E, Suzuki T, Koike K. Emerging roles of exosomal circular RNAs in cancer. Front Cell Dev Biol. 2020;8:568366.","journal-title":"Front Cell Dev Biol"},{"key":"3305_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41419-019-2089-9","volume":"10","author":"Z Liu","year":"2019","unstructured":"Liu Z, Yu Y, Huang Z, Kong Y, Hu X, Xiao W, Quan J, Fan X. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression. Cell Death Dis. 2019;10:900.","journal-title":"Cell Death Dis"},{"key":"3305_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","volume":"5","author":"J Xu","year":"2020","unstructured":"Xu J, Ji L, Liang Y, Wan Z, Zheng W, Song X, Gorshkov K, Sun Q, Lin H, Zheng X, et al. CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Target Ther. 2020;5:298.","journal-title":"Signal Transduct Target Ther"},{"key":"3305_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-019-1046-7","volume":"18","author":"L Wang","year":"2019","unstructured":"Wang L, Long H, Zheng Q, Bo X, Xiao X, Li B. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Mol Cancer. 2019;18:119.","journal-title":"Mol Cancer"},{"key":"3305_CR12","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.18632\/aging.102312","volume":"11","author":"Y Su","year":"2019","unstructured":"Su Y, Lv X, Yin W, Zhou L, Hu Y, Zhou A, Qi F. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Aging (Albany NY). 2019;11:8183\u2013203.","journal-title":"Aging (Albany NY)"},{"key":"3305_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41420-021-00710-x","volume":"7","author":"C Lu","year":"2021","unstructured":"Lu C, Rong D, Hui B, He X, Jiang W, Xu Y, Cao H, Xu Z, Tang W. CircETFA upregulates CCL5 by sponging miR-612 and recruiting EIF4A3 to promote hepatocellular carcinoma. Cell Death Discov. 2021;7:321.","journal-title":"Cell Death Discov"},{"key":"3305_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2174\/1566524019666190507114748","volume":"19","author":"BJ Henriques","year":"2019","unstructured":"Henriques BJ, Lucas TG, Martins E, Gaspar A, Bandeira A, Nogueira C, Brand\u00e3o O, Rocha H, Vilarinho L, Gomes CM. Molecular and clinical investigations on portuguese patients with multiple acyl-CoA dehydrogenase deficiency. Curr Mol Med. 2019;19:487\u201393.","journal-title":"Curr Mol Med"},{"key":"3305_CR15","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1111\/jcmm.16867","volume":"25","author":"W Chen","year":"2021","unstructured":"Chen W, Di Z, Chen Z, Nan K, Gu J, Ge F, Liu J, Zhang H, Miao C. NBPF4 mitigates progression in colorectal cancer through the regulation of EZH2-associated ETFA. J Cell Mol Med. 2021;25:9038\u201350.","journal-title":"J Cell Mol Med"},{"key":"3305_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12964-018-0220-7","volume":"16","author":"GB Carballo","year":"2018","unstructured":"Carballo GB, Honorato JR, de Lopes GPF, Spohr T. A highlight on Sonic hedgehog pathway. Cell Commun Signal. 2018;16:11.","journal-title":"Cell Commun Signal"},{"key":"3305_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41419-020-2441-0","volume":"11","author":"Y He","year":"2020","unstructured":"He Y, Huang H, Jin L, Zhang F, Zeng M, Wei L, Tang S, Chen D, Wang W. CircZNF609 enhances hepatocellular carcinoma cell proliferation, metastasis, and stemness by activating the Hedgehog pathway through the regulation of miR-15a-5p\/15b-5p and GLI2 expressions. Cell Death Dis. 2020;11:358.","journal-title":"Cell Death Dis"},{"key":"3305_CR18","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/cas.13961","volume":"110","author":"J Lin","year":"2019","unstructured":"Lin J, Tan H, Nie Y, Wu D, Zheng W, Lin W, Zhu Z, Yang B, Chen X, Chen T. Kr\u00fcppel-like factor 2 inhibits hepatocarcinogenesis through negative regulation of the Hedgehog pathway. Cancer Sci. 2019;110:1220\u201331.","journal-title":"Cancer Sci"},{"key":"3305_CR19","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1016\/j.bbadis.2019.07.011","volume":"1865","author":"Y Liu","year":"2019","unstructured":"Liu Y, Kim HG, Dong E, Dong C, Huang M, Liu Y, Liangpunsakul S, Dong XC. Sesn3 deficiency promotes carcinogen-induced hepatocellular carcinoma via regulation of the hedgehog pathway. Biochim Biophys Acta Mol Basis Dis. 2019;1865:2685\u201393.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3305_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41419-021-03494-1","volume":"12","author":"Y Xia","year":"2021","unstructured":"Xia Y, Zhen L, Li H, Wang S, Chen S, Wang C, Yang X. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway. Cell Death Dis. 2021;12:326.","journal-title":"Cell Death Dis"},{"key":"3305_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-021-01435-2","volume":"20","author":"Y Gu","year":"2021","unstructured":"Gu Y, Wang Y, He L, Zhang J, Zhu X, Liu N, Wang J, Lu T, He L, Tian Y, Fan Z. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling. Mol Cancer. 2021;20:132.","journal-title":"Mol Cancer"},{"key":"3305_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13059-019-1685-4","volume":"20","author":"WC Liang","year":"2019","unstructured":"Liang WC, Wong CW, Liang PP, Shi M, Cao Y, Rao ST, Tsui SK, Waye MM, Zhang Q, Fu WM, Zhang JF. Translation of the circular RNA circ\u03b2-catenin promotes liver cancer cell growth through activation of the Wnt pathway. Genome Biol. 2019;20:84.","journal-title":"Genome Biol"},{"key":"3305_CR23","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jhep.2018.12.015","volume":"70","author":"J Wu","year":"2019","unstructured":"Wu J, Zhu P, Lu T, Du Y, Wang Y, He L, Ye B, Liu B, Yang L, Wang J, et al. The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signaling. J Hepatol. 2019;70:918\u201329.","journal-title":"J Hepatol"},{"key":"3305_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M. NF-\u03baB and STAT3 - key players in liver inflammation and cancer. Cell Res. 2011;21:159\u201368.","journal-title":"Cell Res"},{"key":"3305_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3748\/wjg.v22.i2.823","volume":"22","author":"V Vilchez","year":"2016","unstructured":"Vilchez V, Turcios L, Marti F, Gedaly R. Targeting Wnt\/\u03b2-catenin pathway in hepatocellular carcinoma treatment. World J Gastroenterol. 2016;22:823\u201332.","journal-title":"World J Gastroenterol"},{"key":"3305_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/hep.29565","volume":"67","author":"JD Riordan","year":"2018","unstructured":"Riordan JD, Feddersen CR, Tschida BR, Beckmann PJ, Keng VW, Linden MA, Amin K, Stipp CS, Largaespada DA, Dupuy AJ. Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in mice. Hepatology. 2018;67:924\u201339.","journal-title":"Hepatology"},{"key":"3305_CR27","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.2147\/CMAR.S310529","volume":"13","author":"W Zhang","year":"2021","unstructured":"Zhang W, Liu Q, Zhao J, Wang T, Wang J. Long noncoding RNA AATBC promotes the proliferation and migration of prostate cancer cell through miR-1245b-5p\/CASK axis. Cancer Manag Res. 2021;13:5091\u2013100.","journal-title":"Cancer Manag Res"},{"key":"3305_CR28","first-page":"9464","volume":"23","author":"RR Wu","year":"2019","unstructured":"Wu RR, Zhong Q, Liu HF, Liu SB. Role of miR-579-3p in the development of squamous cell lung carcinoma and the regulatory mechanisms. Eur Rev Med Pharmacol Sci. 2019;23:9464\u201370.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3305_CR29","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1080\/15548627.2018.1503146","volume":"14","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Yao Z, Wang L, Ding H, Shao J, Chen A, Zhang F, Zheng S. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1\/HuR to regulate ferroptosis in hepatic stellate cells. Autophagy. 2018;14:2083\u2013103.","journal-title":"Autophagy"},{"key":"3305_CR30","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1111\/jcmm.15162","volume":"24","author":"J Li","year":"2020","unstructured":"Li J, Qin X, Wu R, Wan L, Zhang L, Liu R. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605\/FOXO3\/ABCB1 axis. J Cell Mol Med. 2020;24:5152\u201361.","journal-title":"J Cell Mol Med"},{"key":"3305_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13046-020-01769-7","volume":"39","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Song J, Tang B, Fang S, Zhang D, Zheng L, Wu F, Gao Y, Chen C, Hu X, et al. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2\/STAT3 signaling pathway. J Exp Clin Cancer Res. 2020;39:259.","journal-title":"J Exp Clin Cancer Res"},{"key":"3305_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.intimp.2019.05.012","volume":"73","author":"N Li","year":"2019","unstructured":"Li N, Fan X, Wang X, Deng H, Zhang K, Zhang X, Wang Y, Han Q, Lv Y, Liu Z. PRDM1 levels are associated with clinical diseases in chronic HBV infection and survival of patients with HBV-related hepatocellular carcinoma. Int Immunopharmacol. 2019;73:156\u201362.","journal-title":"Int Immunopharmacol"},{"key":"3305_CR33","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41374-018-0089-5","volume":"98","author":"H Zhu","year":"2018","unstructured":"Zhu H, Xia L, Shen Q, Zhao M, Gu X, Bouamar H, Wang B, Sun LZ, Zhu X. Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. Lab Invest. 2018;98:1384\u201396.","journal-title":"Lab Invest"},{"key":"3305_CR34","doi-asserted-by":"publisher","first-page":"112453","DOI":"10.1016\/j.yexcr.2020.112453","volume":"399","author":"Q Wang","year":"2021","unstructured":"Wang Q, Guo Y, Wang W, Liu B, Yang G, Xu Z, Li J, Liu Z. RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA. Exp Cell Res. 2021;399:112453.","journal-title":"Exp Cell Res"},{"key":"3305_CR35","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41418-019-0304-y","volume":"26","author":"M Wang","year":"2019","unstructured":"Wang M, Mao C, Ouyang L, Liu Y, Lai W, Liu N, Shi Y, Chen L, Xiao D, Yu F, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;26:2329\u201343.","journal-title":"Cell Death Differ"},{"key":"3305_CR36","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41419-019-2176-y","volume":"10","author":"Z Yao","year":"2019","unstructured":"Yao Z, Xu R, Yuan L, Xu M, Zhuang H, Li Y, Zhang Y, Lin N. Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11. Cell Death Dis. 2019;10:945.","journal-title":"Cell Death Dis"},{"key":"3305_CR37","first-page":"963689720968748","volume":"29","author":"J Li","year":"2020","unstructured":"Li J, Yu Z, Zhu Q, Tao C, Xu Q. hsa_circ_102559 acts as the sponge of miR-130a-5p to promote hepatocellular carcinoma progression through regulation of ANXA2. Cell Transplant. 2020;29:963689720968748.","journal-title":"Cell Transplant"},{"key":"3305_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.canlet.2019.06.007","volume":"460","author":"YG Wang","year":"2019","unstructured":"Wang YG, Wang T, Ding M, Xiang SH, Shi M, Zhai B. hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307. Cancer Lett. 2019;460:128\u201338.","journal-title":"Cancer Lett"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03305-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03305-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03305-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:18:47Z","timestamp":1649157527000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03305-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3305"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03305-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"28 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were approved by Affiliated Hospital of Guilin Medical College.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}